Optimising Survival and Quality of Survival for Children with Wilms Tumour Through Biomarker Research and Clinical Trials

被引:0
|
作者
Pritchard-Jones, Kathy [1 ]
机构
[1] UCL, Great Ormond St Inst Child Hlth, London, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SY6-1
引用
收藏
页码:S11 / S12
页数:2
相关论文
共 50 条
  • [31] Quality Assurance of Biomarker Assays in Clinical Trials
    Hall, J. A.
    Salgado, R.
    Peters, G. J.
    Martens, J. W. M.
    Sleijfer, S.
    Lacombe, D.
    Harbeck, N.
    Daidone, M. G.
    Sweep, F. C. G. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 137 - 137
  • [32] Incidence of and survival from Wilms' tumour in adults in Europe: Data from the EUROCARE study
    Mitry, Emmanuel
    Ciccolallo, Laura
    Coleman, Michel P.
    Gatta, Gemma
    Jones, Kathy Pritchard
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (14) : 2363 - 2368
  • [33] Systemic inflammatory markers and serum lactate dehydrogenase predict survival in patients with Wilms tumour
    Kunc, Michal
    Gabrych, Anna
    Dulak, Dominika
    Hasko, Karolina
    Styczewska, Malgorzata
    Szmyd, Dagmara
    Nilsson, Kristoffer
    Iwinski, Marek
    Sobocinska-Mirska, Agata
    Sawicka-Zukowska, Malgorzata
    Krawczyk, Malgorzata A.
    Bien, Ewa
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (05) : 1253 - 1261
  • [34] ANALYSIS OF SURVIVAL IN CANCER CLINICAL-TRIALS
    SHIMM, D
    LOGUE, G
    ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 665 - 666
  • [35] OVERALL SURVIVAL VERSUS PROGRESSION-FREE SURVIVAL IN ONCOLOGY CLINICAL TRIALS
    Aissaoui, A.
    Bin Sawad, A.
    Turkistani, F.
    Aissaoui, N.
    VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
  • [36] Coronary artery patency and survival in clinical trials
    Ellis C.J.
    French J.K.
    White H.D.
    Journal of Thrombosis and Thrombolysis, 1997, 4 (2) : 239 - 250
  • [37] Compound optimal allocations for survival clinical trials
    Baldi Antognini, Alessandro
    Novelli, Marco
    Zagoraiou, Maroussa
    Vagheggini, Alessandro
    BIOMETRICAL JOURNAL, 2020, 62 (07) : 1730 - 1746
  • [38] PITFALLS IN ANALYSIS OF SURVIVAL IN CLINICAL-TRIALS
    POWLES, RL
    BIOMEDICINE, 1976, 24 (05): : 327 - 328
  • [39] Prevalence of quality of life(QoL) outcomes and association with survival in cancer clinical trials.
    Gyawali, Bishal
    Hwang, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Generalisation from phase III clinical trials: survival, quality of life, and health economics
    Fayers, PM
    Hand, DJ
    LANCET, 1997, 350 (9083): : 1025 - 1027